Sandoz Group AG Registered Shares SDZ
News
Generic weight-loss drugs? They're coming - eventually, executive says
Sandoz reports second-quarter sales and half-year 2024 results
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation
Sandoz Receives FDA Approval for Wyost, Jubbonti
Novartis Net Profit Boosted by Gain From Sandoz Spinoff — Update
Novartis Net Profit Boosted by Gain From Sandoz Spinoff